Eiken Chemical Co., Ltd.
Notice Regarding Introduction of CxO System and Changes in Executive Officers
Introducing the CxO system effective April 1, 2026, establishing roles of CEO, COO, CMSO, CTO, CPO, CFO, and CHRO. Resolutions on changes in executive officers’ titles and concurrent roles.
Key Figures
- Introduction Date: 2026-04-01
- Number of Established Roles: 7 (CEO, COO, CMSO, CTO, CPO, CFO, CHRO)
- Representative Executive Officer President Yuji Segawa’s Position: Representative Executive Officer President concurrently CEO and COO
AI要約
Overview of the Introduction of the CxO System
Eiken Chemical Co., Ltd. will introduce the CxO system effective April 1, 2026, establishing seven roles: CEO, COO, CMSO, CTO, CPO, CFO, and CHRO. This system appoints executives with expertise in core management areas to enhance the quality of management decisions and accelerate decision-making. The aim is to build a robust management foundation and achieve sustainable enhancement of corporate value.
Changes in Executive Officers and Title Modifications
Effective April 1, 2026, executive officers’ titles will be changed and multiple executives will concurrently hold CxO roles. Representative Executive Officer President Yuji Segawa will concurrently serve as CEO and COO, Executive Officer Senior Managing Director Yoshiyoshi Moriyasu will concurrently serve as CTO. Additionally, the Head of Production will concurrently serve as CPO, the Head of Sales as CMSO, and the Head of Corporate Management as CFO and CHRO, transitioning to a system that strengthens management specialization and facilitates prompt decision-making.
